ProfileGDS4814 / ILMN_1732776
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 80% 82% 84% 79% 83% 85% 81% 82% 79% 81% 83% 80% 82% 83% 82% 84% 83% 82% 83% 83% 83% 83% 82% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)142.6380
GSM780708Untreated after 4 days (C2_1)168.24282
GSM780709Untreated after 4 days (C3_1)207.66384
GSM780719Untreated after 4 days (C1_2)135.13279
GSM780720Untreated after 4 days (C2_2)184.80583
GSM780721Untreated after 4 days (C3_2)225.91385
GSM780710Trastuzumab treated after 4 days (T1_1)164.93781
GSM780711Trastuzumab treated after 4 days (T2_1)176.56782
GSM780712Trastuzumab treated after 4 days (T3_1)132.09979
GSM780722Trastuzumab treated after 4 days (T1_2)155.05881
GSM780723Trastuzumab treated after 4 days (T2_2)190.53283
GSM780724Trastuzumab treated after 4 days (T3_2)148.67280
GSM780713Pertuzumab treated after 4 days (P1_1)173.1782
GSM780714Pertuzumab treated after 4 days (P2_1)183.55883
GSM780715Pertuzumab treated after 4 days (P3_1)179.30282
GSM780725Pertuzumab treated after 4 days (P1_2)218.56284
GSM780726Pertuzumab treated after 4 days (P2_2)190.76883
GSM780727Pertuzumab treated after 4 days (P3_2)180.00782
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)189.36683
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)196.39783
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)181.24483
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)194.89883
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)179.30282